DP

Diadema Partners Portfolio holdings

AUM $242M
1-Year Est. Return 182.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+182.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$242M
AUM Growth
+$74.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
162
New
Increased
Reduced
Closed

Top Buys

1 +$9.57M
2 +$8.62M
3 +$7.79M
4
COGT icon
Cogent Biosciences
COGT
+$7.05M
5
VKTX icon
Viking Therapeutics
VKTX
+$6.05M

Top Sells

1 +$7.95M
2 +$6.74M
3 +$4.21M
4
BIOA
BioAge Labs
BIOA
+$4.07M
5
CORT icon
Corcept Therapeutics
CORT
+$3.27M

Sector Composition

1 Healthcare 92.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
1
Viking Therapeutics
VKTX
$3.43B
$17.1M 7.06%
525,181
+188,332
UTHR icon
2
United Therapeutics
UTHR
$22.7B
$16.2M 6.69%
27,303
+17,303
JNJ icon
3
Johnson & Johnson
JNJ
$537B
$13.1M 5.43%
53,771
-12,673
COGT icon
4
Cogent Biosciences
COGT
$5.61B
$12.4M 5.13%
322,764
+190,912
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$14.2B
$10.4M 4.27%
+54,755
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
$9.58M 3.96%
181,752
-164,128
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$10.4B
$8.37M 3.46%
148,229
+1,868
ABVX
8
Abivax
ABVX
$5.64B
$8.22M 3.39%
75,944
+300
RVMD icon
9
Revolution Medicines
RVMD
$32.6B
$7.86M 3.25%
80,872
+43,852
KOD icon
10
Kodiak Sciences
KOD
$2.14B
$7.36M 3.04%
+192,962
INCY icon
11
Incyte
INCY
$18.8B
$7.34M 3.03%
+78,029
TGTX icon
12
TG Therapeutics
TGTX
$5.61B
$6.87M 2.84%
206,928
+83,645
BBIO icon
13
BridgeBio Pharma
BBIO
$12.4B
$6.34M 2.62%
85,311
+15,311
IMCR icon
14
Immunocore
IMCR
$1.45B
$5.82M 2.41%
193,189
+122,889
LLY icon
15
Eli Lilly
LLY
$952B
$5.52M 2.28%
6,000
+4,000
ABBV icon
16
AbbVie
ABBV
$375B
$5.23M 2.16%
+24,058
RCUS icon
17
Arcus Biosciences
RCUS
$3.05B
$5.14M 2.12%
+238,142
CRBP icon
18
Corbus Pharmaceuticals
CRBP
$133M
$4.13M 1.71%
+439,957
CRVS icon
19
Corvus Pharmaceuticals
CRVS
$969M
$3.58M 1.48%
+244,811
ZYME icon
20
Zymeworks
ZYME
$1.79B
$3.56M 1.47%
+142,132
GPCR icon
21
Structure Therapeutics
GPCR
$2.62B
$3.48M 1.44%
+72,234
GLUE icon
22
Monte Rosa Therapeutics
GLUE
$1.55B
$3.08M 1.27%
187,307
+125,026
TENX icon
23
Tenax Therapeutics
TENX
$296M
$2.87M 1.19%
179,738
-63,432
HRMY icon
24
Harmony Biosciences
HRMY
$1.83B
$2.6M 1.07%
92,864
+85,364
CAPR icon
25
Capricor Therapeutics
CAPR
$1.57B
$2.4M 0.99%
78,851
-79,224